Executive Summary The Infantile Systemic Hyalinosis Market is a specialized segment within the rare genetic disorder therapeutics landscape. Characterized by the mutation of the ANTXR2 (CMG2) gene, this condition leads to widespread hyaline deposition in various tissues, causing severe joint contractures, skin nodules, and protein-losing enteropathy. The market is primarily...